SCN2A – Patient Worthy

Source: Pixabay.com

FDA Designations Granted to PRAX-222, PRAX-562 for Epileptic Encephalopathies

Post author:Jessica Lynn
Post published:January 12, 2021
Post category:Status epilepticus

According to a recent press release from biopharmaceutical company Praxis Precision Medicines ("Praxis"), two of the company's drug candidates received either Orphan Drug or Rare Pediatric Disease designations for rare…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More